Overview
Transient congenital hypothyroidism due to neonatal factor is a temporary form of thyroid hormone deficiency present at birth that is caused by factors originating in the newborn infant rather than from maternal or environmental causes. Neonatal factors that can lead to this condition include prematurity, low birth weight, neonatal illness, hepatic hemangiomas (which increase the activity of type 3 deiodinase, an enzyme that inactivates thyroid hormones), and certain genetic variations affecting thyroid hormone metabolism in the neonatal period. The condition primarily affects the endocrine system, but because thyroid hormones are critical for normal brain development and metabolic function, untreated hypothyroidism — even when transient — can impact the nervous system, growth, and overall development. Affected newborns may present with clinical features typical of congenital hypothyroidism, including prolonged jaundice, feeding difficulties, decreased activity or lethargy, constipation, hypothermia, a large fontanelle, hypotonia (poor muscle tone), dry skin, and a hoarse cry. However, many cases are detected through routine newborn screening programs before overt clinical signs develop, as the condition is identified by elevated thyroid-stimulating hormone (TSH) and/or low free thyroxine (T4) levels on screening blood tests. The hallmark of this condition is its transient nature — thyroid function normalizes over weeks to months as the underlying neonatal factor resolves. Treatment typically involves levothyroxine (synthetic thyroid hormone) replacement therapy initiated promptly after diagnosis to protect neurodevelopment during the critical neonatal period. Clinicians generally recommend a trial off therapy at around 2–3 years of age (or earlier in some cases) to confirm that hypothyroidism has resolved. Close monitoring of thyroid function is essential during and after treatment to ensure appropriate dosing and to confirm the transient nature of the condition. Prognosis is generally excellent when treatment is initiated early and appropriately.
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Transient congenital hypothyroidism due to neonatal factor.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Transient congenital hypothyroidism due to neonatal factor at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Transient congenital hypothyroidism due to neonatal factor.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Transient congenital hypothyroidism due to neonatal factor.
Community
No community posts yet. Be the first to share your experience with Transient congenital hypothyroidism due to neonatal factor.
Start the conversation →Latest news about Transient congenital hypothyroidism due to neonatal factor
No recent news articles for Transient congenital hypothyroidism due to neonatal factor.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Transient congenital hypothyroidism due to neonatal factor
What is Transient congenital hypothyroidism due to neonatal factor?
Transient congenital hypothyroidism due to neonatal factor is a temporary form of thyroid hormone deficiency present at birth that is caused by factors originating in the newborn infant rather than from maternal or environmental causes. Neonatal factors that can lead to this condition include prematurity, low birth weight, neonatal illness, hepatic hemangiomas (which increase the activity of type 3 deiodinase, an enzyme that inactivates thyroid hormones), and certain genetic variations affecting thyroid hormone metabolism in the neonatal period. The condition primarily affects the endocrine sy
How is Transient congenital hypothyroidism due to neonatal factor inherited?
Transient congenital hypothyroidism due to neonatal factor follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Transient congenital hypothyroidism due to neonatal factor typically begin?
Typical onset of Transient congenital hypothyroidism due to neonatal factor is neonatal. Age of onset can vary across affected individuals.